Maryland State Retirement & Pension System’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,810	Closed	-$635K	–	1511
2025 Q1	$635K	Sell	4,810 -1,069	-18%	-$133K	0.02%	783
2024 Q4	$491K	Hold	5,879	–	–	0.01%	1069
2024 Q3	$430K	Sell	5,879 -2,139	-27%	-$161K	0.01%	1162
2024 Q2	$549K	Buy	+8,018	New	+$556K	0.01%	1074

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maryland State Retirement & Pension System's ITCI Position: Q2 2025 in Review

Maryland State Retirement & Pension System sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 4,810 shares — an estimated $635K sold.

Maryland State Retirement & Pension System first reported a position in ITCI in Q2 2024 and held it in 4 quarters. The position peaked at $635K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Maryland State Retirement & Pension System reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Maryland State Retirement & Pension System sold 4,810 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $635K.
Maryland State Retirement & Pension System first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 4 quarters.
Maryland State Retirement & Pension System's Intra-Cellular Therapies Inc. position peaked at $635K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2025, filed 23 Jul 2025.